According to its provisional consolidated earnings report, APR Corp recorded revenue of KRW385.9bn (USD267m) and operating profit of KRW96.1bn (USD66.5m) for Q3 2025.
These figures represent year-over-year growth of 122% in revenue and 253% in operating profit, marking the company’s highest quarterly performance to date.
“Despite the impact of new US tariff policy in Q3 2025, APR Corp achieved a strong 24.9% operating margin, maintaining three consecutive quarters of outperforming market expectations. Driven by this momentum, we are now certain to reach our full-year goal of KRW1tn (USD681) in revenue,” the company stated.
For the first three quarters of 2025, cumulative revenue totalled KRW979.7bn (USD 678m), more than double of last year’s figure, while cumulative operating profit reached KRW235.2bn (USD163m), surpassing the KRW200bn (USD136m) milestone for the first time.
In fact, the company had already exceeded its total 2024 operating profit (KRW122.7bn or USD83.6m) by the first half of 2025, with the final “new record” to be determined by its fourth-quarter performance.
Overseas revenue up 210%
The cosmetics and beauty divisions were key growth drivers in Q3 2025, said APR Corp.
Powered by surging global demand for K-beauty products, the cosmetics segment generated KRW 272.3bn (USD189m) in quarterly revenue — three times higher than the same period last year for the second consecutive quarters.
The company’s flagship skin care brand, medicube, has continued to expand its global footprint.
Alongside its best-selling Zero Pore Pad, various product lines, particularly the PDRN ranges which surpassed 15m cumulative global sales, saw strong performance across the local, US and international markets.
The beauty device division also maintained steady growth, with revenue of KRW103.1bn (USD71m), up 39% year-over-year.
As of September 2025, global cumulative sales of medicube’s AGE-R beauty devices have exceeded 5m units, with more than half of total device sales now coming from overseas.
“This reflects robust demand from global retail customers and the successful launches of new products.”
As a whole, APR Corp’s international business posted a remarkable 210% year-over-year increase, exceeding KRW300bn (USD204m) in quarterly overseas sales for the first time.
“Overseas revenue accounted for 80% of total sales. The US, representing 39% of total revenue, surpassed KRW150bn (USD102m) in quarterly sales, driven by strong results from various promotions, including Amazon Prime Day and expanded distribution channels.”
In Japan, medicube ranked first in the beauty category during Qoo10’s Mega-Wari (a major quarterly sales event of the e-commerce platform), while regions such as Europe and South East Asia recorded nearly four times higher sales compared to same period last year.
Sustaining momentum through holiday season
On the back of its Q3 results, APR Corp plans to further strengthen its performance in the fourth quarter, which constitutes the year’s biggest shopping season, encompassing Black Friday, Christmas, and New Year holidays.
It will build on the popularity of K-beauty among foreign consumers by intensifying its global marketing and sales efforts to sustain growth momentum through year-end.
“Thanks to the enthusiastic support from global consumers, our cosmetics business delivered exceptional growth and helped drive record results in Q3. We will continue working to maximise performance across both domestic and international markets in the fourth quarter,” the company reiterated.
